Patterns of ethnic diversity among the genes that influence AIDS

Human Molecular Genetics

Volumn 13, Issue REV. ISS. 1, 2004, Pages

  Winkler, Cheryl ^a   An, Ping ^a   O'Brien, Stephen J ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; EOTAXIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; STROMAL CELL DERIVED FACTOR 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE ASSOCIATION; DNA RESTRICTION; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC DRIFT; GENETIC SELECTION; GENETIC VARIABILITY; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RESISTANCE; LIFE CYCLE; MALARIA; MIGRATION; MORTALITY; NATURAL SELECTION; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CONTINENTAL POPULATION GROUPS; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HIV; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 1842579451     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Ingman, M., Kaessmann, H., Paabo, S. and Gyllensten, U. (2000) Mitochondrial genome variation and the origin of modern humans. Nature, 408, 708-713.
2. Clark, A.G., Weiss, K.M., Nickerson, D.A., Taylor, S.L., Buchanan, A., Stengard, J., Salomaa, V., Vartiainen, E., Perola, M., Boerwinkle, E. et al. (1998) Haplotype structure and population genetic inferences from nucleotide- sequence variation in human lipoprotein lipase. Am. J. Hum. Genet., 63, 595-612.
3. Stringer, C. (2003) Human evolution: Out of Ethiopia. Nature, 423, 692-695.
4. White, T.D., Asfaw, B., DeGusta, D., Gilbert, H., Richards, G.D., Suwa, G. and Howell, F.C. (2003) Pleistocene Homo sapiens from Middle Awash, Ethiopia. Nature, 423, 742-747.
5. Nei, M. (1970) Effective size of human populations. Am. J. Hum. Genet., 22, 694-696.
6. Nei, M. and Takahata, N. (1993) Effective population size, genetic diversity, and coalescence time in subdivided populations. J. Mol. Evol., 37, 240-244.
7. Reich, D.E., Schaffner, S.F., Daly, M.J., McVean, G., Mullikin, J.C., Higgins, J.M., Richter, D.J., Lander, E.S. and Altshuler, D. (2002) Human genome sequence variation and the influence of gene history, mutation and recombination. Nat. Genet., 32, 135-142.
8. Chakraborty, R., Kamboh, M.I. and Ferrell, R.E. (1991) 'Unique' alleles in admixed populations: A strategy for determining 'hereditary' population differences of disease frequencies. Ethnic Dis., 1, 245-256.
9. Chakraborty, R. and Weiss, K.M. (1988) Admixture as a tool for finding linked genes and detecting that difference from allelic association between loci. Proc. Natl Acad. Sci. USA, 85, 9119-9123.
10. Briscoe, D., Stephens, J.C. and O'Brien, S.J. (1994) Linkage disequilibrium in admixed populations: Applications in gene mapping. J. Hered., 85, 59-63.
11. Lautenberger, J.A., Stephens, J.C., O'Brien, S.J. and Smith, M.W. (2000) Significant admixture linkage disequilibrium in African Americans across 30 cM around the FY locus. Am. J. Hum. Genet., 66, 969-978.
12. Fortin, A., Stevenson, M.M. and Gros, P. (2002) Susceptibility to malaria as a complex trait: Big pressure from a tiny creature. Hum. Mol. Genet., 11, 2469-2478.
13. Garte, S. (2003) Locus-specific genetic diversity between human populations: An analysis of the literature. Am. J. Human. Biol., 15, 814-823.
14. Tishkoff, S.A., Varkonyi, R., Cahinhinan, N., Abbes, S., Argyropoulos, G., Destro-Bisol, G., Drousiotou, A., Dangerfield, B., Lefranc, G., Loiselet, J. et al. (2001) Haplotype diversity and linkage disequilibrium at human G6PD: Recent origin of alleles that confer malarial resistance. Science, 293, 455-462.
15. Joy, D.A., Feng, X., Mu, J., Furuya, T., Chotivanich, K., Krettli, A.U., Ho, M., Wang, A., White, N.J., Suh, E. et al. (2003) Early origin and recent expansion of Plasmodium falciparum. Science, 300, 318-321.
16. Centers for Disease Control (1987) Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbid. Mortal. Wkly Rep., 36 (Suppl. 1), 1-15S.
17. Pisani, E., Schwartlander, B., Cherney, S. and Winter, A. (June 2000) Report of the global HIV/AIDS epidemic. Joint United Nations Programme on AIDS, Geneva.
18. Weatherall, D.J. (1998) The phenotypic diversity of monogenic disease: Lessons from the thalassemias. Harvey Lect., 94, 1-20.
19. Hill, A.V. (1992) Malaria resistance genes: A natural selection. Trans. R. Soc. Trap. Med. Hyg., 86, 225-226, 232.
20. Hill, A.V., Jepson, A., Plebanski, M. and Gilbert, S.C. (1997) Genetic analysis of host-parasite coevolution in human malaria. Phil. Trans. R. Soc. Lond. B Biol. Sci., 352, 1317-1325.
21. Miller, L.H., Mason, S.J., Clyde, D.F. and McGinniss, M.H. (1976) The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. New Engl. J. Med., 295, 302-304.
22. Gilles, H.M., Fletcher, K.A., Hendrickse, R.G., Lindner, R., Reddy, S. and Allan, N. (1967) Glucose-6-phosphate-dehydrogenase deficiency, sickling, and malaria in African children in South Western Nigeria. Lancet, 1, 138-140.
23. Williams, T.N., Maitland, K., Bennett, S., Ganczakowski, M., Peto, T.E., Newbold, C.I., Bowden, D.K., Weatherall, D.J. and Clegg, J.B. (1996) High incidence of malaria in alpha-thalassaemic children. Nature, 383, 522-525.
24. Sabeti, P.C., Reich, D.E., Higgins, J.M., Levine, H.Z., Richter, D.J., Schaffner, S.F., Gabriel, S.B., Platko, J.V., Patterson, N.J., McDonald, G.J. et al. (2002) Detecting recent positive selection in the human genome from haplotype structure. Nature, 419, 832-837.
25. Saunders, M.A., Hammer, M.F. and Nachman, M.W. (2002) Nucleotide variability at G6pd and the signature of malarial selection in humans. Genetics, 162, 1849-1861.
26. Tishkoff, S.A. and Verrelli, B.C. (2003) Patterns of human genetic diversity: Implications for human evolutionary history and disease. A. Rev. Genomics Hum. Genet., 4, 293-340.
27. Verrelli, B.C., McDonald, J.H., Argyropoulos, G., Destro-Bisol, G., Froment, A., Drousiotou, A., Lefranc, G., Helal, A.N., Loiselet, J. and Tishkoff, S.A. (2002) Evidence for balancing selection from nucleotide sequence analyses of human G6PD. Am. J. Hum. Genet., 71, 1112-1128.
28. Stephens, J.C., Reich, D.E., Goldstein, D.B., Shin, H.D., Smith, M.W., Carrington, M., Winkler, C., Huttley, G.A., Allikmets, R., Schriml, L. et al. (1998) Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am. J. Hum. Genet., 62, 1507-1515.
29. Bamshad, M.J., Mummidi, S., Gonzalez, E., Ahuja, S.S., Dunn, D.M., Watkins, W.S., Wooding, S., Stone, A.C., Jorde, L.B., Weiss, R.B. et al. (2002) A strong signature of balancing selection in the 5′ cis-regulatory region of CCR5. Proc. Natl Acad. Sci. USA, 99, 10539-10544.
30. Galvani, A.P. and Slatkin, M. (2003) Evaluating plague and smallpox as historical selective pressures for the CCR5-{Delta}32 HIV-resistance allele. Proc. Natl Acad. Sci. USA, 100, 15276-15279.
31. Schliekelman, P., Garner, C. and Slatkin, M. (2001) Natural selection and resistance to HIV Nature, 411, 545-546.
32. Nei, M. and Roychoudhury, A.K. (1974) Genic variation within and between the three major races of man, Caucasoids, Negroids, and Mongoloids. Am. J. Hum. Genet., 26, 421-443.
33. Romualdi, C., Balding, D., Nasidze, I.S., Risch, G., Robichaux, M., Sherry, S.T., Stoneking, M., Batzer, M.A. and Barbujani, G. (2002) Patterns of human diversity, within and among continents, inferred from biallelic DNA polymorphisms. Genome Res., 12, 602-612.
34. Shriver, M.D., Smith, M.W., Jin, L., Marcini, A., Akey, J.M., Deka, R. and Ferrell, R.E. (1997) Ethnic-affiliation estimation by use of population-specific DNA markers. Am. J. Hum. Genet., 60, 957-964.
35. Akey, J.M., Zhang, G., Zhang, K., Jin, L. and Shriver, M.D. (2002) Interrogating a high-density SNP map for signatures of natural selection. Genome Res., 12, 1805-1814.
36. Phair, J., Jacobson, L., Detels, R., Rinaldo, C., Saah, A., Schrager, L. and Munoz, A. (1992) Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: The Multicenter AIDS Cohort Study. J. AIDS, 5, 490-496.
37. Detels, R., Liu, Z., Hennessey, K., Kan, J., Visscher, B.R., Taylor, J.M., Hoover, D.R., Rinaldo, C.R., Jr., Phair, J.P., Saah, A.J. et al. (1994) Resistance to HIV-1 infection. Multicenter AIDS Cohort Study J. AIDS, 7, 1263-1269.
38. CDC (2001) HIV/AIDS Surveillance Report. Centers for Disease Control, Atlanta, GA.
39. Cheng-Mayer, C., Shioda, T. and Levy, J.A. (1991) Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J. Virol., 65, 6931-6941.
40. Shioda, T., Levy, J.A. and Cheng-Mayer, C. (1992) Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA, 89, 9434-9438.
41. Richman, D.D. and Bozzette, S.A. (1994) The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis., 169, 968-974.
42. Kanki, P.J., Hamel, D.J., Sankale, J.L., Hsieh, C., Thior, I., Barin, F., Woodcock, S.A., Gueye-Ndiaye, A., Zhang, E., Montano, M. et al. (1999) Human immunodeficiency virus type 1 subtypes differ in disease progression. J. Infect. Dis., 179, 68-73.
43. Renjifo, B., Fawzi, W., Mwakagile, D., Hunter, D., Msamanga, G., Spiegelman, D., Garland, M., Kagoma, C., Kim, A., Chaplin, B. et al. (2001) Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes. J. Hum. Virol., 4, 16-25.
44. Roof, P., Ricci, M., Genin, P., Montano, M.A., Essex, M., Wainberg, M.A., Gatignol, A. and Hiscott, J. (2002) Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator. Virology, 296, 77-83.
45. O'Brien, S.J., Dean, M., Smith, M., Winkler, C., Nelson, G.W., Martin, M.P. and Carrington, M. (2000) The human genes that limit AIDS. In Boulyjenkov, V., Berg, K. and Christen, Y. (eds), Genes and Resistence to Diseases, 1st edn, Springer, Berlin, pp. 9-17.
46. Gonzalez, E., Dhanda, R., Bamshad, M., Mummidi, S., Geevarghese, R., Catano, G., Anderson, S.A., Walter, E.A., Stephan, K.T., Hammer, M.F. et al. (2001) Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: Impact on the epidemiology of the HIV-1 pandemic. Proc. Natl Acad. Sci. USA, 98, 5199-5204.
47. Winkler, C., Modi, W., Smith, M.W., Nelson, G.W., Wu, X., Carrington, M., Dean, M., Honjo, T., Tashiro, K., Yabe, D. et al. (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science, 279, 389-393.
48. Winkler, C.A. and O'Brien, S.J. (2002) Effect of Genetic Variation on HIV Transmission and Progression to AIDS. In Essex, M., Mboup, M., Kanki, P., Marlink, R. and Thou, S. (eds), AIDS in Africa, 2nd edn, Kluwer Academy/Plenum, New York.
49. Gonzalez, E., Bamshad, M., Sato, N., Mummidi, S., Dhanda, R., Catano, G., Cabrera, S., McBride, M., Cao, X.H., Merrill, G. et al. (1999) Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc. Natl Acad. Sci. USA, 96, 12004-12009.
50. Mummidi, S., Ahuja, S.S., Gonzalez, E., Anderson, S.A., Santiago, E.N., Stephan, K.T., Craig, F.E., O'Connell, P., Tryon, V., Clark, R.A. et al. (1998) Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat. Med., 4, 786-793.
51. An, P., Martin, M.P., Nelson, G.W., Carrington, M., Smith, M.W., Gong, K., Vlahov, D., O'Brien, S.J. and Winkler, C.A. (2000) Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans. AIDS, 14, 2117-2122.
52. Anzala, A.O., Ball, T.B., Rostron, T., O'Brien, S.J., Plummer, F.A. and Rowland-Jones, S.L. (1998) CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research. Lancet, 351, 1632-1633.
53. Carrington, M. and O'Brien, S.J. (2003) The influence of HLA genotype on AIDS. A. Rev. Med., 54, 535-551.
54. Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Smith, M.W., Allikmets, R., Goedert, J.J., Buchbinder, S.P., Vittinghoff, E., Gomperts, E. et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science, 273, 1856-1862.
55. Ioannidis, J.P., O'Brien, T.R., Rosenberg, P.S., Contopoulos-Ioannidis, D.G. and Goedert, J.J. (1998) Genetic effects on HIV disease progression. Nat. Med., 4, 536.
56. Martin, M.P., Dean, M., Smith, M.W., Winkler, C., Gerrard, B., Michael, N.L., Lee, B., Doms, R.W., Margolick, J., Buchbinder, S. et al. (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science, 282, 1907-1911.
57. Martin, M.P., Gao, X., Lee, J.H., Nelson, G.W., Detels, R., Goedert, J.J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J. et al. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet., 31, 429-434.
58. Smith, M.W., Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Lomb, D.A., Goedert, J.J., O'Brien, T.R., Jacobson, L.P., Kaslow, R. et al. (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science, 277, 959-965.
59. Alkhatib, G., Combadiere, C., Broder, C.C., Feng, Y., Kennedy, P.E., Murphy, P.M. and Berger, E.A. (1996) CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science, 272, 1955-1958.
60. Bleul, C.C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. and Springer, T.A. (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 382, 829-833.
61. Dragic, T., Litwin, V., Allaway, G.P., Martin, S.R., Huang, Y., Nagashima, K.A., Cayanan, C., Maddon, P.J., Koup, R.A., Moore, J.P. et al. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC- CKR-5. Nature, 381, 667-673.
62. Feng, Y., Broder, C.C., Kennedy, P.E. and Berger, E.A. (1996) HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. [See comments.] Science, 272, 872-877.
63. Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R., MacDonald, M.E., Stuhlmann, H., Koup, R.A. and Landau, N.R. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 86, 367-377.
64. Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C. et al. (1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382, 722-725.
65. Zimmerman, P.A., Buckler-White, A., Alkhatib, G., Spalding, T., Kubofcik, J., Combadiere, C., Weissman, D., Cohen, O., Rubbert, A., Lam, G. et al. (1997) Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med., 3, 23-36.
66. Greene, W.C. and Peterlin, B.M. (2002) Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nat. Med., 8, 673-680.
67. Tournamille, C., Colin, Y., Cartron, J.P. and Le Van Kim, C. (1995) Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet., 10, 224-228.
68. O'Brien, S.J. and Moore, J.P. (2000) The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol. Rev., 177, 99-111.
69. Lalani, A.S., Masters, J., Zeng, W., Barrett, J., Pannu, R., Everett, H., Arendt, C.W. and McFadden, G. (1999) Use of chemokine receptors by poxviruses. Science, 286, 1968-1971.
70. Carrington, M., Dean, M., Martin, M.P. and O'Brien, S.J. (1999) Genetics of HIV-1 infection: Chemokine receptor CCR5 polymorphism and its consequences. Hum. Mol. Genet., 8, 1939-1945.
71. Carrington, M., Kissner, T., Gerrard, B., Ivanov, S., O'Brien, S.J. and Dean, M. (1997) Novel alleles of the chemokine-receptor gene CCR5. Am. J. Hum. Genet., 61, 1261-1267.
72. Ober, C., Leavitt, S.A., Tsalenko, A., Howard, T.D., Hoki, D.M., Daniel, R., Newman, D.L., Wu, X., Parry, R., Lester, L.A. et al. (2000) Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am. J. Hum. Genet., 66, 517-526.
73. Alonso, K., Pontiggia, P., Medenica, R. and Rizzo, S. (1997) Cytokine patterns in adults with AIDS. Immunol. Invest., 26, 341-350.
74. Annunziato, F., Cosmi, L., Galli, G., Beltrame, C., Romagnani, P., Manetti, R., Romagnani, S. and Maggi, E. (1999) Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J. Leukoc. Biol., 65, 691-699.
75. Constant, S.L. and Bottomly, K. (1997) Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches. A. Rev. Immunol., 15, 297-322.
76. Shin, H.D., Winkler, C., Stephens, J.C., Bream, J., Young, H., Goedert, J.J., O'Brien, T.R., Vlahov, D., Buchbinder, S., Giorgi, J. et al. (2000) Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc. Natl Acad. Sci. USA, 97, 14467-14472.
77. Roychoudhury, A.K. and Nei, M. (1988) Human Polymorphic Genes: World Distribution. Oxford University Press, New York.
78. Cardon, L.R. and Abecasis, G.R. (2003) Using haplotype blocks to map human complex trait loci. Trends Genet., 19, 135-140.
79. An, P., Nelson, G.W., Wang, L., Donfield, S., Goedert, J.J., Phair, J., Vlahov, D., Buchbinder, S., Farrar, W.L., Modi, W. et al. (2002) Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc. Natl Acad. Sci. USA, 99, 10002-10007.
80. Goddard, K.A., Hopkins, P.J., Hall, J.M. and Witte, J.S. (2000) Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations. Am. J. Hum. Genet., 66, 216-234.
81. Long, J.C., Williams, R.C., McAuley, J.E., Medis, R., Partel, R., Tregellas, W.M., South, S.F., Rea, A.E., McCormick, S.B. and Iwaniec, U. (1991) Genetic variation in Arizona Mexican Americans: Estimation and interpretation of admixture proportions. Am. J. Phys. Anthropol., 84, 141-157.
82. Chakraborty, R., Kamboh, M.I., Nwankwo, M. and Ferrell, R.E. (1992) Caucasian genes in American blacks: New data. Am. J. Hum. Genet., 50, 145-155.
83. Modi, W.S., Goedert, J.J., Strathdee, S., Buchbinder, S., Roger, D., Donfield, S., O'Brien, S.J. and Winkler, C.A. (2003) MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS, 17, 2357-2365.
84. Mellado, M., Rodriquez-Frade, J.M., Vila-Coro, A.J., Fernandez, S., Martine de Ana, A., Jones, D.R., Toran, J.L. and Martinez, A.C. (2001) Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J., 20, 2497-2507.
85. Wang, F.S., Hong, W.G., Cao, Y., Liu, M.X., Jin, L., Hu, L.P., Wang, Z., Feng, T.J., Hou, J., Zhang, B. et al. (2003) Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDF1 3′A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups. J. AIDS, 32, 124-130.
86. Annunziato, F., Galli, G., Nappi, F., Cosmi, L., Manetti, R., Maggi, E., Ensoli, B. and Romagnani, S. (2000) Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta. Blood, 95, 1167-1174.
87. Benyoucef, S., Hober, D., De Groote, D., Bocket, L., De La Tribonniere, X., Mouton, Y. and Wattre, P. (1998) RANTES production in HIV-1 antigen-stimulated whole blood culture: Relationship with type-1 immune response and plasma viral load in individuals infected with HIV-1. Scand. J. Immunol., 48, 212-216.
88. De Clercq, E. and Schols, D. (2001) Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. Antivir. Chem. Chemother, 12 (Suppl. 1), 19-31.
89. Hadida, F., Vieillard, V., Mollet, L., Clark-Lewis, I., Baggiolini, M. and Debre, P. (1999) Cutting edge: RANTES regulates Fas ligand expression and killing by HIV-specific CD8 cytotoxic T cells. J. Immunol., 163, 1105-1109.
90. Liu, H., Chao, D., Nakayama, E.E., Taguchi, H., Goto, M., Xin, X., Takamatsu, J., Saito, H., Ishikawa, Y., Akaza, T. et al. (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc. Natl Acad. Sci. USA, 96, 4581-4585.
91. McDermott, D.H., Beecroft, M.J., Kleeberger, C.A., Al-Sharif, F.M., Ollier, W.E., Zimmerman, P.A., Boatin, B.A., Leitman, S.F., Detels, R., Hajeer, A.H. et al. (2000) Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study AIDS, 14, 2671-2678.
92. Van Coillie, E., Van Damme, J. and Opdenakker, G. (1999) The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev., 10, 61-86.
93. Gong, W., Howard, O.M., Turpin, J.A., Grimm, M.C., Ueda, H., Gray, P.W., Raport, C.J., Oppenheim, J.J. and Wang, J.M. (1998) Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. J. Biol. Chem., 273, 4289-4292.
94. Mengozzi, M., De Filippi, C., Transidico, P., Biswas, P., Cota, M., Ghezzi, S., Vicenzi, E., Mantovani, A., Sozzani, S. and Poli, G. (1999) Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells. Blood, 93, 1851-1857.
95. Schols, D., Proost, P., Van Damme, J. and De Clercq, E. (1997) RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE). J. Virol., 71, 7300-7304.
96. Bream, J.H., Ping, A., Zhang, X., Winkler, C. and Young, H.A. (2002) A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription. Genes Immun., 3, 165-169.
97. An, P., Vlahov, D., Margolick, J., Phair, J., O'Brien, T.R., Lautenberger, J., O'Brien, S.J. and Winkler, C.A. (2003) A TNF-a inducible promoter variant of interferon-gamma accelerates CD4 T cell depletion in HIV-1 infected individuals. J. Inf. Dis., 188, 228-231.
98. Duggal, P., An, P., Beaty, T.H., Strathdee, S.A., Farzadegan, H., Markham, R.B., Johnson, L., O'Brien, S.J., Vlahov, D. and Winkler, C. (2003) Genetic Influence of CXCR6 chemokine receptor alleles on PCP mediated AIDS progression among African Americans. Genes Immun., 4, 245-250.
99. Carrington, M., Nelson, G.W., Martin, M.P., Kissner, T., Vlahov, D., Goedert, J.J., Kaslow, R., Buchbinder, S., Hoots, K. and O'Brien, S.J. (1999) HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science, 283, 1748-1752.
100. Gao, X., Nelson, G.W., Karacki, P., Martin, M.P., Phair, J., Kaslow, R., Goedert, J.J., Buchbinder, S., Hoots, K., Vlahov, D. et al. (2001) Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. New Engl. J. Med., 344, 1668-1675.
101. Barber, L.D., Gillece-Castro, B., Percival, L., Li, X., Clayberger, C. and Parham, P. (1995) Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr. Biol., 5, 179-190.
102. Hill, A.V. (1998) The immunogenetics of human infectious diseases. A. Rev. Immunol., 16, 593-617.
103. Hill, A.V. (1996) Genetic susceptibility to malaria and other infectious diseases: From the MHC to the whole genome. Parasitology, 112 (suppl.), S75-S84.
104. Hill, A.V., Allsopp, C.E., Kwiatkowski, D., Anstey, N.M., Twumasi, P., Rowe, P.A., Bennett, S., Brewster, D., McMichael, A.J. and Greenwood, B.M. (1991) Common west African HLA antigens are associated with protection from severe malaria. Nature, 352, 595-600.
105. Altman, J.D., Moss, P.A.H., Goulder, P.J.R., Barouch, D.H., McHeyzer-Williams, M.G., Bell, J.I., McMichael, A.J. and Davis, M.M. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science, 274, 94-96.
106. Rowland-Jones, S., Dong, T., Krausa, P., Sutton, J., Newell, H., Ariyoshi, K., Gotch, F., Sabally S., Corrah, T., Kimani, J. et al. (1998) The role of cytotoxic T-cells in HIV infection. Dev. Biol. Stand., 92, 209-214.
107. Klenerman, P., Wu, Y. and Phillips, R. (2002) HIV: Current opinion in escapology. Curr. Opin. Microbiol., 5, 408-413.
108. McEvedy, C. (1988) The bubonic plague. Sci. Am., 258, 118-123.